A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer

This publication has 21 references indexed in Scilit:

• A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)
  Annals of Oncology, 1994
• Pancreatic cancer: the greatest oncological challenge
  BMJ, 1988
• Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.
  Proceedings of the National Academy of Sciences, 1986
• Chemotherapy for advanced pancreatic cancer.A comparison of 5-fluorouracil, adriamycin, and mitomycin (fam) with 5-fluorouracil, streptozotocin, and mitomycin (fsm)
  Cancer, 1986
• Phase II study of epirubicin in advanced adenocarcinoma of the pancreas
  European Journal of Cancer and Clinical Oncology, 1985
• Reporting results of cancer treatment
  Cancer, 1981
• Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial.
  BMJ, 1980
• 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer. A Southwest oncology group study
  Cancer, 1979
• Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features.
  1977
• A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer
  Cancer, 1974